宫癌的分子标及其微环境:治疗方面的进展
Joe Youssef1, Amal El Masri1, Maya Atwi1
1Department of Anatomy, Cell Biology and Physiological Sciences, American University of Beirut, Beirut 1107-2020, Lebanon.
Cancers
|February 27, 2026
概括
宫癌的治疗方法正在进步,新疗法如免疫疗法和抗体-药物合物显示出对晚期疾病的承诺. 目前正在进行的研究正在探索新的治疗方法和组合,以改善患者的生存和结果.
科学领域:
- 妇科瘤学 妇科瘤学
- 癌症病理生理学 癌症病理生理学
- 翻译医学是一种翻译医学.
背景情况:
- 宫癌是全球妇女死亡的主要原因,尽管有预防性疫苗.
- 高危人乳头瘤病毒 (HPV) 是宫癌发生的主要原因,涉及改变细胞增殖和免疫微环境调节.
研究的目的:
- 审查目前和新兴的宫癌治疗策略,特别是晚期,复发性,持久性或转移性疾病.
- 要突出推动宫癌治疗发展的分子基础.
主要方法:
- 审查关于宫癌治疗的现有文献.
- 分析分子特征及其治疗含义.
- 对各种治疗方式的临床试验结果的讨论.
主要成果:
- 贝瓦西祖马布和Endostar可以改善晚期宫癌的存活率.
- 提索托马布 (Tisotumab Vedotin) 通过抗体与药物联合体提供向治疗.
- 免疫疗法 (针对PD1,PD-L1,CTLA4) 是一种关键的治疗方式.
- 抗血管性氨酸激酶抑制剂的疗效有限.
结论:
- 在宫癌治疗方面取得了重大进展,包括抗血管原剂,抗体药物合物和免疫疗法.
- 针对HPV E6/E7蛋白的治疗性疫苗正在研究中,但需要进一步的临床验证.
- 目前正在进行的临床试验正在评估用于宫癌的新疗法和治疗组合.
相关概念视频
Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
The Tumor Microenvironment
8.0K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.0K
Treatment Resistant Cancers
3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Cancer Vaccines
1.2K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.2K
Cancer Therapies
10.3K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.3K
Metastasis
6.7K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.7K


